Leukemia & Lymphoma, Volume 65, Issue 3 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 65, Issue 3 (2024)

See all volumes and issues
Volume 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Review Article

Review Article
BCMA-directed therapy, new treatments in the myeloma toolbox, and how to use them
Matthew James Rees & Shaji Kumar
Pages: 287-300
Published online: 21 Nov 2023
AbstractforBCMA-directed therapy, new treatments in the myeloma toolbox, and how to use them | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 367 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas
Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John Reneau, Daniel Addison, Pierluigi Porcu & Jonathan Edward Brammer
Pages: 301-311
Published online: 13 Dec 2023
AbstractforGemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 183 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I–II follicular lymphoma from the SEER database (2000–2015)
Qiuzi Zhong, Ye Liu, Yunpeng Wu, Xin Liu, Siye Chen, Bo Chen, Fei Su, Gaofeng Li, Yonggang Xu, Lipin Liu, Fan Chen, Shunan Qi & Yexiong Li
Pages: 312-322
Published online: 21 Nov 2023
AbstractforImpact of age on long-term relative survival benefit of radiotherapy for early-stage grade I–II follicular lymphoma from the SEER database (2000–2015) | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma
Michael Dickinson, Joaquin Martinez-Lopez, Etienne Jousseaume, Hongbo Yang, Xinglei Chai, Cheryl Xiang, Travis Wang, Jie Zhang, Roberto Ramos, Stephen J. Schuster & Nathan Fowler
Pages: 323-332
Published online: 05 Jan 2024
AbstractforComparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 376 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma
Chonlada Laoruangroj, Pamela J. Atherton, Gregory A. Wiseman, Stephen Ansell, Andrew L. Feldman, Peyton Schumacher & Thomas E. Witzig
Pages: 333-338
Published online: 08 Jan 2024
AbstractforThe asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma | Full Text | References | PDF (888.5 KB) | EPUB
  • 897 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma
Yuto Kaneda, Nobuhiro Kanemura, Nobuhiko Nakamura, Yoshikazu Ikoma, Kimihiro Yamaguchi, Eri Takada, Yuhei Shibata, Shin Lee, Kei Fujita, Tetsuji Morishita, Takuro Matsumoto, Hiroshi Nakamura, Junichi Kitagawa, Senji Kasahara, Takeshi Hara, Hisashi Tsurumi & Masahito Shimizu
Pages: 339-345
Published online: 20 Dec 2023
AbstractforThe pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma | Full Text | References | PDF (974.2 KB) | EPUB | Supplemental
  • 110 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis
Jowon Laura Kim, Alina S. Gerrie, Kerry Joane Savage, Diego Villa, David Scott, Jeffrey W. Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie H. Sehn, Christopher Venner & Ciara L. Freeman
Pages: 346-352
Published online: 29 Dec 2023
AbstractforFrontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 128 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of coadministration of venetoclax and anti-fungal agents under therapeutic drug monitor in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome with neutropenia: a single-center retrospective study
Lihong Wang, Liang Gao, Zeyin Liang, Xinan Cen, Hanyun Ren & Yujun Dong
Pages: 353-362
Published online: 09 Dec 2023
AbstractforEfficacy and safety of coadministration of venetoclax and anti-fungal agents under therapeutic drug monitor in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome with neutropenia: a single-center retrospective study | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 229 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission
Xiaoxuan Lai, Jinyan Xiao, Tanzhen Wang, Chang Hou, Jia Chen, Depei Wu & Yang Xu
Pages: 363-371
Published online: 22 Nov 2023
AbstractforPrognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission | Full Text | References | PDF (2.2 MB) | EPUB
  • 143 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib
Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Pourhassan, Ahmed Aribi, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Karamjeet Sandhu, Vinod Pullarkat, Brian Ball & Paul Koller
Pages: 372-377
Published online: 02 Jan 2024
AbstractforTreatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib | Full Text | References | PDF (924.4 KB) | EPUB
  • 318 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients
Wei-Ying Jen, Koji Sasaki, Caitlin R. Rausch, Courtney D. DiNardo, Tapan M. Kadia, Musa Yilmaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah McCue, Hagop M. Kantarjian & Farhad Ravandi
Pages: 378-382
Published online: 06 Dec 2023
AbstractforAcute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients | Full Text | References | PDF (1 MB) | EPUB
  • 216 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Outcomes of haploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in pediatric myeloid neoplasms post cytotoxic therapy: a case series study
Feng Zhang, Guan-hua Hu, Le-ping Zhang, Lan-ping Xu, Pan Suo, Yu Wang, Lu Bai, Kai-yan Liu, Xiao-hui Zhang, Xiao-jun Huang & Yi-fei Cheng
Pages: 383-388
Published online: 03 Dec 2023
First Page PreviewforOutcomes of haploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in pediatric myeloid neoplasms post cytotoxic therapy: a case series study | Full Text | References | PDF (486.3 KB) | EPUB
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric
Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience
Karan L. Chohan, Radhika Bansal, Matthew A. Hathcock, Jonas Paludo, Nora N. Bennani, Patrick B. Johnston, Arushi Khurana, Urshila Durani, Yucai Wang, Michael W. Ruff, Jose C. Villasboas Bisneto, Stephen M. Ansell, Yi Lin & Saad S. Kenderian
Pages: 389-393
Published online: 30 Nov 2023
First Page PreviewforReal-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 200 Views
  • 0 CrossRef citations
  • 0Altmetric
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro, Amanda Isabel Perez-Valencia, Alexandra Martinez-Roca, Olga Balaguer, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, Montserrat Rovira, Dolors Colomer, Marina Diaz-Beyá, Maria Rozman & Jordi Esteve
Pages: 394-398
Published online: 20 Dec 2023
First Page PreviewforA novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition | Full Text | References | PDF (3.7 MB) | EPUB
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
Maria T. Kuipers, Anne M. Spanjaart, Francesca Bonifazi, Roberta diBlasi, Pier L. Zinzani, Catherine Thieblemont, Mathilde Baudet, Bart J. Biemond, Wouter E. M. Kok & Marie J. Kersten
Pages: 399-402
Published online: 09 Dec 2023
First Page PreviewforFeasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma | Full Text | References | PDF (1.8 MB) | EPUB
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric
Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC)
Daniel Levin, Ellen Lewis, Sylvia McCulloch, Holly Lee, Jason Tay, Peter Duggan, Paola Neri, Nizar Bahlis & Victor H. Jimenez-Zepeda
Pages: 403-406
Published online: 06 Dec 2023
First Page PreviewforDaratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC) | Full Text | References | PDF (408.4 KB) | EPUB
  • 115 Views
  • 0 CrossRef citations
  • 0Altmetric
Attempted desensitization to calaspargase pegol: a familiar approach to a new problem
Alexis K. Kuhn, Catherine Martin, Paul Galardy, Kristen McCullough, Jacob Greenmyer, Madeleine O’Keefe, Ashley Walter, Christineil Thompson, Asmaa Ferdjallah, Jessica Kalmes & Mira Kohorst
Pages: 407-409
Published online: 22 Nov 2023
First Page PreviewforAttempted desensitization to calaspargase pegol: a familiar approach to a new problem | Full Text | References | PDF (395.8 KB) | EPUB
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric
Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone
Kai-Ni Shen, Dan-Qing Zhao, Yue-Ying Mao, Hua-Cong Cai, Jian Li & Xin-Xin Cao
Pages: 410-412
Published online: 29 Nov 2023
First Page PreviewforDaratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone | Full Text | References | PDF (718.6 KB) | EPUB
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles